Mdxhealth Sa Adr Stock Performance
| MDXH Stock | USD 1.98 0.02 1.00% |
The company secures a Beta (Market Risk) of 0.74, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MDxHealth's returns are expected to increase less than the market. However, during the bear market, the loss of holding MDxHealth is expected to be smaller as well. At this point, MDxHealth SA ADR has a negative expected return of -0.53%. Please make sure to verify MDxHealth's potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if MDxHealth SA ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MDxHealth SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor 1:10 | Last Split Date 2023-11-14 |
1 | MDxHealth launches offering of ordinary shares | 09/25/2024 |
2 | Crude Oil Down Over 2 US Initial Jobless Claims Fall | 09/26/2024 |
3 | MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6 | 10/14/2024 |
4 | MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024 | 11/06/2024 |
5 | MDxHealth SA Non-GAAP EPS of -0.40, revenue of 23.3M | 11/07/2024 |
6 | Bleichroeder LP Acquires New Stake in Scientific Industries Inc | 11/14/2024 |
7 | MDxHealth to Participate in Piper Sandler Healthcare Conference | 11/25/2024 |
| Begin Period Cash Flow | 15.5 M |
MDxHealth |
MDxHealth Relative Risk vs. Return Landscape
If you would invest 292.00 in MDxHealth SA ADR on September 4, 2024 and sell it today you would lose (94.00) from holding MDxHealth SA ADR or give up 32.19% of portfolio value over 90 days. MDxHealth SA ADR is currently does not generate positive expected returns and assumes 3.8473% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than MDxHealth, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MDxHealth Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MDxHealth's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MDxHealth SA ADR, and traders can use it to determine the average amount a MDxHealth's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1369
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDXH |
Estimated Market Risk
| 3.85 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.53 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MDxHealth is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MDxHealth by adding MDxHealth to a well-diversified portfolio.
MDxHealth Fundamentals Growth
MDxHealth Stock prices reflect investors' perceptions of the future prospects and financial health of MDxHealth, and MDxHealth fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MDxHealth Stock performance.
| Return On Equity | -2.41 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 104.07 M | ||||
| Shares Outstanding | 49.5 M | ||||
| Price To Book | 5.77 X | ||||
| Price To Sales | 1.16 X | ||||
| Revenue | 70.19 M | ||||
| Gross Profit | 19.22 M | ||||
| EBITDA | (30.47 M) | ||||
| Net Income | (43.1 M) | ||||
| Cash And Equivalents | 40.02 M | ||||
| Cash Per Share | 2.57 X | ||||
| Total Debt | 41.27 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 2.38 X | ||||
| Book Value Per Share | 0.61 X | ||||
| Cash Flow From Operations | (21.5 M) | ||||
| Earnings Per Share | (1.53) X | ||||
| Market Capitalization | 98 M | ||||
| Total Asset | 129.13 M | ||||
| Retained Earnings | (331.45 M) | ||||
| Working Capital | 18.64 M | ||||
About MDxHealth Performance
By evaluating MDxHealth's fundamental ratios, stakeholders can gain valuable insights into MDxHealth's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MDxHealth has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MDxHealth has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 38.62 | 40.90 | |
| Return On Tangible Assets | (0.88) | (0.93) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.33) | (0.35) | |
| Return On Equity | (5.98) | (5.68) |
Things to note about MDxHealth SA ADR performance evaluation
Checking the ongoing alerts about MDxHealth for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MDxHealth SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MDxHealth SA ADR generated a negative expected return over the last 90 days | |
| MDxHealth SA ADR may become a speculative penny stock | |
| MDxHealth SA ADR has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 70.19 M. Net Loss for the year was (43.1 M) with profit before overhead, payroll, taxes, and interest of 19.22 M. | |
| MDxHealth SA ADR currently holds about 40.02 M in cash with (21.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| MDxHealth SA ADR has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: MDxHealth to Participate in Piper Sandler Healthcare Conference |
- Analyzing MDxHealth's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MDxHealth's stock is overvalued or undervalued compared to its peers.
- Examining MDxHealth's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MDxHealth's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MDxHealth's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MDxHealth's stock. These opinions can provide insight into MDxHealth's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MDxHealth Stock analysis
When running MDxHealth's price analysis, check to measure MDxHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MDxHealth is operating at the current time. Most of MDxHealth's value examination focuses on studying past and present price action to predict the probability of MDxHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MDxHealth's price. Additionally, you may evaluate how the addition of MDxHealth to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |